Focus
Our Focus
Pipeline
Dystrophic EB
Netherton Syndrome
TGM1-deficient ARCI
Cystic Fibrosis
Aesthetic Skin Conditions
Chronic Skin Diseases
Patients and Families
Our gene therapy
Our STAR-D platform
Our Targets
Patient Advocacy
Medical Professionals
About Us
Investors
Contact
Contact Us
Careers
Contact Us
Search for:
Homepage-1
We are leading
the development
of corrective and
redosable gene
therapies to offer
hope to patients
facing debilitating
rare diseases.
Learn More
Homepage-1 - copy
At Krystal, we
are driven by
our mission to
develop innovative
gene therapies to
dramatically improve
people’s lives.
Learn More
Dystrophic Epidermolysis Bullosa
B-VEC
READ MORE
TGM1-deficient ARCI
KB105
READ MORE
Cystic Fibrosis
KB407
READ MORE
Netherton Syndrome
KB104
READ MORE
Additional Dermatological Indications
Our Therapies
READ MORE
